Tunisian Lung Cancer Study

Launched by DACIMA CONSULTING · Apr 11, 2025

Keywords

ClinConnect Summary

The Tunisian Lung Cancer Study is a research project designed to learn more about lung cancer, which is a serious disease affecting the lungs. This study will look at patients who have been diagnosed with lung cancer at different stages of the disease. The goal is to gather detailed information about these patients' conditions and treatments over time to help improve care and outcomes for others with lung cancer.

To participate in this study, individuals must be at least 18 years old and have a confirmed diagnosis of lung cancer at least three months prior to joining. They should also be receiving treatment in specific medical departments, such as pulmonology or oncology. There are no specific exclusions for this trial, meaning that most patients with a confirmed diagnosis can participate. Although the study is not yet recruiting patients, those who join can expect to share information about their health and treatment experiences, which will contribute to a better understanding of lung cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age more than 18 years
• • Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
• • Informed consent
• Exclusion Criteria:
• • None